Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
Details for Australian Patent Application No. 2010219363 (hide)
International Classifications
Event Publications
23 September 2010 Complete Application Filed
30 September 2010 Application Open to Public Inspection
Published as AU-A-2010219363
21 October 2010 Alteration of Name
The name of the applicant has been altered to Abgenix Fremont Inc. 2010221798 4Life Research, LC The name of the applicant has been altered to 4LIFE RESEARCH, LLC
2 December 2010 Corrigenda
Change of Names(s) of Applicant(s), Section 104 - 2010 Under the name Abgenix Fremont Inc., Application No. 2010219363, under INID (71) correct the applicant name to Amgen Fremont Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2010219364-Novel use of adenoviruses and nucleic acids coding therefor
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser